Indian drugmaker Dr. Reddy’s agreed to pay $5 million to settle claims it distributed prescription drugs in the U.S. with packaging that wasn’t tested for child safety. In its suit against Dr. Reddy’s ...

(Reuters) - Dr. Reddy's Laboratories Ltd will pay $5 million to resolve U.S. claims that the Indian company sold prescription drugs in the United States in packaging that was not tested for child ...

Regulators around the world can be strict when it comes to protecting children against the accidental use of meds. India's Dr. Reddy's is getting up close and personal with two U.S. agencies over that ...

Dr. Reddy’s Laboratories was fined $5 million for allegedly violating federal law by distributing household oral prescription drugs in blister packs that were not child resistant, according to the ...

Shares of Dr Reddy’s dropped over 2 per cent in Thursday’s trade after the US Consumer Product Safety Commission (CPSC) sought civil penalty against the Hyderabad-headquartered drugmaker, saying it ...

Dr. Reddy's Laboratories Ltd will pay $5 million to resolve U.S. claims that the Indian company sold prescription drugs in the United States in packaging that was not tested for child safety, ...